Literature DB >> 11741213

Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates.

I S Nestorov1, S T Hadjitodorov, I Petrov, M Rowland.   

Abstract

The aim of the current study was to compare the predictive performance of a mechanistically based model and an empirical artificial neural network (ANN) model to describe the relationship between the tissue-to-unbound plasma concentration ratios (Kpu's) of 14 rat tissues and the lipophilicity (LogP) of a series of nine 5-n-alkyl-5-ethyl barbituric acids. The mechanistic model comprised the water content, binding capacity, number of the binding sites, and binding association constant of each tissue. A backpropagation ANN with 2 hidden layers (33 neurons in the first layer, 9 neurons in the second) was used for the comparison. The network was trained by an algorithm with adaptive momentum and learning rate, programmed using the ANN Toolbox of MATLAB. The predictive performance of both models was evaluated using a leave-one-out procedure and computation of both the mean prediction error (ME, showing the prediction bias) and the mean squared prediction error (MSE, showing the prediction accuracy). The ME of the mechanistic model was 18% (range, 20 to 57%), indicating a tendency for overprediction; the MSE is 32% (range, 6 to 104%). The ANN had almost no bias: the ME was 2% (range, 36 to 64%) and had greater precision than the mechanistic model, MSE 18% (range, 4 to 70%). Generally, neither model appeared to be a significantly better predictor of the Kpu's in the rat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11741213      PMCID: PMC2751347          DOI: 10.1208/ps010417

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  19 in total

1.  Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.

Authors:  I Nestorov; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

2.  Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?

Authors:  P Veng-Pedersen; N B Modi
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

3.  The use and abuse of models.

Authors:  A Rescigno; J S Beck
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

Review 4.  The backpropagation neural network--a Bayesian classifier. Introduction and applicability to pharmacokinetics.

Authors:  R J Erb
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

5.  Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks.

Authors:  J V Gobburu; W H Shelver
Journal:  J Pharm Sci       Date:  1995-07       Impact factor: 3.534

6.  Application of neural networks to pharmacodynamics.

Authors:  P Veng-Pedersen; N B Modi
Journal:  J Pharm Sci       Date:  1993-09       Impact factor: 3.534

Review 7.  Introduction to backpropagation neural network computation.

Authors:  R J Erb
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

8.  Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data.

Authors:  A S Hussain; R D Johnson; N N Vachharajani; W A Ritschel
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

9.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

10.  Neural network predicted peak and trough gentamicin concentrations.

Authors:  M E Brier; J M Zurada; G R Aronoff
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

View more
  5 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysis.

Authors:  S H Kang; M R Poynton; K M Kim; H Lee; D H Kim; S H Lee; K S Bae; O Linares; S E Kern; G J Noh
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

3.  Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities.

Authors:  Panos G Georgopoulos; Alan F Sasso; Sastry S Isukapalli; Paul J Lioy; Daniel A Vallero; Miles Okino; Larry Reiter
Journal:  J Expo Sci Environ Epidemiol       Date:  2008-03-26       Impact factor: 5.563

4.  Prediction of drug distribution in rat and humans using an artificial neural networks ensemble and a PBPK model.

Authors:  Paulo Paixão; Natália Aniceto; Luís F Gouveia; José A G Morais
Journal:  Pharm Res       Date:  2014-05-28       Impact factor: 4.200

5.  Continuous direct compression: Development of an empirical predictive model and challenges regarding PAT implementation.

Authors:  B Bekaert; B Van Snick; K Pandelaere; J Dhondt; G Di Pretoro; T De Beer; C Vervaet; V Vanhoorne
Journal:  Int J Pharm X       Date:  2021-12-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.